Skip to main content
SpringerLink
Log in

Kann eine Langzeitbehandlung mit Antipsychotika zu strukturellen Hirnschäden führen? Pro

Can long-term treatment with antipsychotic drugs lead to structural brain damage? Pro

  • Pro und Kontra
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Lepping P, Sambhi RS, Whittington R et al (2011) Clinical relevance of findings in trials of antipsychotics: systematic review. Br J Psychiatry 198(5):341–345

    Article  PubMed  Google Scholar 

  2. Jin H, Shih PA, Golshan S et al (2013) Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. J Clin Psychiatry 74(1):10–18

    Article  PubMed  Google Scholar 

  3. Pantelis C, Yücel M, Wood SJ et al (2005) Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull 31(3):672–696

    Article  PubMed  Google Scholar 

  4. Madsen AL, Keidling N, Karle A et al (1998) Neuroleptics in progressive structural brain abnormalities in psychiatric illness. Lancet 352(9130):784–785

    Article  PubMed  CAS  Google Scholar 

  5. Ho B-C, Andreasen NC, Ziebell S et al (2011) Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 68(2):128–137

    Article  PubMed  Google Scholar 

  6. Radua J, Borgwardt S, Crescini A et al (2012) Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication. Neuroscience and biobehavioral reviews. Neurosci Biobehav Rev 36(10):2325–2333

    Article  PubMed  CAS  Google Scholar 

  7. Lieberman JA, Tollefson GD, Charles C et al (2005) Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62(4):361–370

    Article  PubMed  CAS  Google Scholar 

  8. Thompson PM, Bartzokis G, Hayashi KM et al (2009) Time-lapse mapping of cortical changes in schizophrenia with different treatments. Cereb Cortex 19(5):1107–1023

    Article  PubMed  Google Scholar 

  9. Haren NE van, Hulshoff Pol EH et al (2008) Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry 63(1):106–113

    Article  PubMed  Google Scholar 

  10. Crespo-Facorro B, Roiz-Santiáñez R, Pérez-Iglesias R et al (2008) Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Prog Neuropsychopharmacol Biol Psychiatry 32(8):1936–1943

    Article  PubMed  CAS  Google Scholar 

  11. Roiz-Santiáñez R, Tordesillas-Gutiérrez D, Ortíz-García de la Foz V et al (2012) Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Schizophr Res 141(1):22–28

    Article  PubMed  Google Scholar 

  12. Dorph-Petersen KA, Pierri JN, Perel JM et al (2005) The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30(9):1649–1661

    Article  PubMed  CAS  Google Scholar 

  13. Vernon AC, Natesan S, Modo M, Kapur S (2011) Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. Biol Psychiatry 69(10):936–944

    Article  PubMed  CAS  Google Scholar 

  14. Konopaske GT, Dorph-Petersen K-A, Sweet RA et al (2008) Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry 63(8):759–765

    Article  PubMed  CAS  Google Scholar 

  15. Ukai W, Ozawa H, Tateno M et al (2004) Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol. J Neural Transm 111(6):667–681

    Article  PubMed  CAS  Google Scholar 

  16. Selemon LD, Rajkowski G, Goldman-Rakic PS (1995) Abnormal high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 52(10):805–818

    Article  PubMed  CAS  Google Scholar 

Download references

Einhaltung der ethischen Richtlinien

Interessenkonflikt. V. Aderhold, S. Weinmann, C. Hägele und A. Heinz geben an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Institut für Sozialpsychiatrie an der Ernst-Moritz-Arndt-Universität Greifswald, Ellernholzstr. 1–2, 17487, Greifswald, Deutschland

    V. Aderhold

  2. Deutsche Gesellschaft für Internationale Zusammenarbeit, Köthener Str. 2, 10963, Berlin, Deutschland

    S. Weinmann

  3. Klinik für Psychiatrie and Psychotherapie, Charité – Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Deutschland

    C. Hägele & A. Heinz

Authors
  1. V. Aderhold
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Weinmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Hägele
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Heinz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Aderhold.

Additional information

Dieser Beitrag ist Teil einer Pro-und-Kontra-Debatte. Den zugehörigen Kontra-Standpunkt finden Sie unter http://dx.doi.org/10.1007/s00115-013-3816-6.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aderhold, V., Weinmann, S., Hägele, C. et al. Kann eine Langzeitbehandlung mit Antipsychotika zu strukturellen Hirnschäden führen? Pro. Nervenarzt 84, 1117–1119 (2013). https://doi.org/10.1007/s00115-013-3815-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-013-3815-7

Search

Navigation